SONOMA PHARMACEUTICALS, INC. Additional Paid in Capital, Common Stock
SONOMA PHARMACEUTICALS, INC. (SNOA) had Additional Paid in Capital, Common Stock of $210.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $210.91M.
- 2026-03-31: Additional Paid in Capital, Common Stock $207.32M.
- 2025-12-31: Additional Paid in Capital, Common Stock $207.02M.
- 2025-09-30: Additional Paid in Capital, Common Stock $206.73M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $210.91M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $207.32M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $207.02M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $206.73M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $206.67M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $206.59M 10-K · filed 2026-06-16 | |
| 2024-12-31 | $206.45M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | $205.65M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $204.07M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $203.21M 10-K · filed 2025-06-17 | $203.21M 10-K · filed 2024-06-17 |
| 2023-12-31 | $202.79M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $201.21M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $201.08M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $200.90M 10-K · filed 2024-06-17 | |
| 2022-12-31 | $197.94M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $197.70M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $197.58M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $197.37M 10-K · filed 2023-06-21 | |
| 2021-12-31 | $197.16M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $196.44M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $189.27M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $189.22M 10-K · filed 2022-07-13 | |
| 2020-12-31 | $189.09M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $188.70M 10-Q · filed 2020-11-20 | |
| 2020-06-30 | $188.11M 10-Q/A · filed 2020-11-17 | |
| 2020-03-31 | $186.56M 10-K · filed 2021-07-14 | |
| 2019-12-31 | $186.26M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $184.50M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $184.37M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $184.07M 10-K · filed 2020-07-10 | |
| 2018-12-31 | $183.77M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $178.63M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $178.00M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $176.74M 10-K · filed 2019-07-01 | |
| 2017-12-31 | $171.33M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $169.67M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $169.20M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $168.71M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $168.20M 10-Q · filed 2017-02-17 | |
| 2016-09-30 | $167.19M 10-Q · filed 2016-11-15 | |
| 2016-06-30 | $166.78M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $166.37M 10-K · filed 2017-06-28 | $166.37M 10-K · filed 2016-06-21 |
| 2015-12-31 | $162.48M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $160.89M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $159.27M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $157.77M 10-K · filed 2016-06-21 | |
| 2014-12-31 | $151.91M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $151.34M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $150.54M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $149.14M 10-K · filed 2015-06-16 | |
| 2013-12-31 | $147.93M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $145.48M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $145.16M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $144.82M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $141.49M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $135.94M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $135.38M 10-Q/A · filed 2012-08-31 | |
| 2012-03-31 | $134.50M 10-K · filed 2013-06-25 | $134.50M 10-K · filed 2012-06-21 |
| 2011-12-31 | $133.87M 10-Q · filed 2012-02-10 | |
| 2011-09-30 | $130.94M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $130.41M 10-Q/A · filed 2011-08-09 | |
| 2011-03-31 | $129.58M 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |